New Classifications of Five Distinct “Sleep” Profi... ...
Science in the Age of AI | AI for Science Forum...
A Professional Overview of Hypertension ...
NAD⁺ restores memory in Alzheimer's disease models...
High-speed imaging tracks live brain cell activity...
A Professional Overview of Hypertension ...
From baby aisle to lunchbox: The rise of commercial squeeze ...
March 02,2026
Rethinking recurrent brain activity: Core neurons provide an...
March 01,2026
Reducing social isolation protects the brain in later life, ...
February 28,2026
Early-stage clinical trial demonstrates promise of intranasa...
February 27,2026
Psilocybin shows greater potential than cannabinoids for obs...
February 26,2026
Should you worry about melatonin and heart failure? The evid...
December 02,2025
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Los 20 tipos de cáncer más comunes: causas, síntomas y tratamiento

Los 20 tipos de cáncer más comunes: causas, síntomas y tratamiento

Los 20 tipos de cáncer más comunes: causas, síntomas y tratamientoRepasamos cuáles son los subtipos de esta enfermedad que afectan a más gente a nivel mundial.Pol Bertran PrietoMicrobiólogo, divulgado
World medicine November 28,2023
Los 20 tipos de cáncer más comunes: causas, síntomas y tratamiento

Los 20 tipos de cáncer más comunes: causas, síntomas y tratamiento

Los 20 tipos de cáncer más comunes: causas, síntomas y tratamientoRepasamos cuáles son los subtipos de esta enfermedad que afectan a más gente a nivel mundial.Pol Bertran PrietoMicrobiólogo, divulgado
World medicine November 28,2023
Today's News
Why is Alzheimer’s disease so difficult to treat? ...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
Announcement of the 2025 Nobel Prize in ...
Why MDMA did NOT get FDA approval...
More News
A Window to the Womb: Leveraging AI and Retinal Vascular Imaging for Early, Non-Invasive Diagnosis of Preeclampsia

A Window to the Womb: Leveraging AI and Retinal Vascular Imaging for Early, Non-Invasive Diagnosis of Preeclampsia

Preeclampsia is a leading cause of maternal and fetal morbidity and mortality, affecting 2–8% of pregnancies globally. Each year, it accounts for approximately 46,000 maternal and over 500,000 fetal deaths, disproportionately burdening low-resource settin
Technology & AI July 25,2025
A Window to the Womb: Leveraging AI and Retinal Vascular Imaging for Early, Non-Invasive Diagnosis of Preeclampsia

A Window to the Womb: Leveraging AI and Retinal Vascular Imaging for Early, Non-Invasive Diagnosis of Preeclampsia

Preeclampsia is a leading cause of maternal and fetal morbidity and mortality, affecting 2–8% of pregnancies globally. Each year, it accounts for approximately 46,000 maternal and over 500,000 fetal deaths, disproportionately burdening low-resource settin
Technology & AI July 25,2025
Launch of the Sleep Health Network Ecosystem Initiative

Launch of the Sleep Health Network Ecosystem Initiative

On July 27, 2025, the Traditional Chinese Medicine (TCM) Globalization Event will take place in Beijing, China, with the aim of promoting the international dissemination of TCM and advancing global health cooperation.
Sleep July 25,2025
Launch of the Sleep Health Network Ecosystem Initiative

Launch of the Sleep Health Network Ecosystem Initiative

On July 27, 2025, the Traditional Chinese Medicine (TCM) Globalization Event will take place in Beijing, China, with the aim of promoting the international dissemination of TCM and advancing global health cooperation.
Sleep July 25,2025
More News
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com